Research Paper Volume 15, Issue 12 pp 5713—5733
MAGOH is correlated with poor prognosis and is essential for cell proliferation in lower-grade glioma
Figure 3. Clinical correlation analysis of MAGOH expression in LGG samples in the TCGA database. (A) Correlations between MAGOH expression and clinical features of LGG. (B) Analysis of MAGOH expression as a function of distinct clinical traits, including gender, age, tumor grade, 1p/19q, IDH status, and MGMT status. (C) Kaplan-Meier analysis of OS in LGG patients with high and low MAGOH expression. (D) Distribution of risk score, OS, and OS status in the high and low MAGOH subgroups. (E) Detailed survival analysis of LGG patients in the high and low MAGOH subgroups. (F) ROC curves of the association between risk scores and survival in the high and low MAGOH subgroups. (G, H) Univariate and multivariate Cox analyses of the associations of MAGOH expression and clinical characteristics with OS. *P < 0.05, **P < 0.01, ***P < 0.001.